HomeTagsAstellas Pharma

Astellas Pharma

Biotechnology

Astellas and Pantherna Enter into a New Technology Evaluation Agreement

PR Newswire - October 4, 2022

Astellas Pharma Inc. and Pantherna Therapeutics GmbH announced that the companies have entered into a new technology evaluation agreement for research to generate mRNA-based...

Biotechnology

Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle

PR Newswire - December 2, 2021

Astellas Pharma Inc. and Dyno Therapeutics, Inc. announced an option and license agreement was signed on November 23 to develop next-generation adeno-associated virus (AAV)...